Naseem Amin is a prominent figure in the pharmaceutical and healthcare sectors, currently serving as a Member of the Board of Directors at Avadel Pharmaceuticals plc and as the Chief Executive Officer and Board Member at Orphalan since October 2017. Additional leadership roles include being a Member of the Board of Trustees for the Pakistan Education Foundation and The British Pakistan Foundation, along with significant contributions as Chairman and Non-Executive Director at Bellerophon Therapeutics until May 2024. Naseem Amin also held the position of Executive Chairman at Arix Bioscience plc from April 2020 to April 2021 and was a Venture Partner at Advent Life Sciences LLP from January 2015 to April 2020. A former Chief Scientific Officer at Smith & Nephew Plc and SVP of Business Development at Biogen Idec, Amin has an extensive educational background with an MBA from Northwestern University's Kellogg School of Management and medical degrees from UCL.
Sign up to view 0 direct reports
Get started
This person is not in any teams